证券代码：839725 证券简称：惠丰钻石 公告编号：2025-042 惠丰钻石股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 惠丰钻石股份有限公司 2024 年年度权益分派方案已获 2025 年 5 月 27 日召 开的股东会审议通过，本次实施分配方案距离股东会审议通过的时间未超过两个 月。 现将权益分派事宜公告如下： 本次权益分派基准日合并报表归属于母公司的未分配利润为 223,739,500.56 元，母公司未分配利润为 210,603,779.95 元。本次权益分派共计派发现金红利 9,066,500.00 元。 一、权益分派方案 按总股本折算的每股现金红利=参与分配的股份数量*（每 10 股分红金额÷ 10）÷总股本=90,665,000*(1.00÷10) ÷91,275,000=0.0993317； 除权除息参考价格为： 1、本公司 2024 年年度权益分派方案为： 以公司股权登记日应分配股数 90,665,000 股为基数（应分配总股数等于 ...

证券代码：839725 证券简称：惠丰钻石 公告编号：2025-040 惠丰钻石股份有限公司 2024 年年度股东会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 5 月 27 日 2.会议召开地点：河南省郑州市商务外环路 17 号格拉姆大厦 A 座 2505 会议 室 3.会议召开方式：现场及网络召开 4.会议召集人：董事会 5.会议主持人：董事长王来福先生 6.召开情况合法合规的说明： 本次股东会的召集、召开、议案审议程序等符合《公司法》及《公司章程》 的相关规定，所作决议合法有效。 3.公司董事会秘书出席会议； 4.公司其他高级管理人员列席会议。 二、议案审议情况 （一）审议通过《关于公司<2024 年年度报告和摘要>的议案》 1.议案表决结果： （二）会议出席情况 出席和授权出席本次股东会的股东共 6 人，持有表决权的股份总数 64,645,850 股，占公司有表决权股份总数的 71.3019%。 其中通过网络 ...

北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 关于惠丰钻石股份有限公司 2024 年年度股东会的 法律意见书 国枫律股字[2025]A0295 号 致：惠丰钻石股份有限公司（贵公司） 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司 2024 年年度股东会（以下简称"本次会议"）。 3．本所及经办律师依据《证券法》《证券法律业务管理办法》《证券法律业务执 业规则》等规定及本法律意见书出具日以前已经发生或者存在的事实，严格履行了法定 职责，遵循了勤勉尽责和诚实信用原则，进行了充分的核查验证，保证本法律意见所认 定的事实真实、准确、完整，所发表的结论性意见合法、准确，不存在虚假记载、误导 性陈述或者重大遗漏，并承担相应法律责任； 4．本法律意见书仅供贵公司本次会议之目的使用，不得用作任何其他用途。本所 律师同意将本法律意见书随贵公司本次会议决议一起予以公告。 本所律师根据《公司法》《证券法》《上市公司股东会规则》《证券法律业务管理 办法》《证券法 ...

Group 1: Market Overview - The People's Bank of China conducted a 7-day reverse repo operation of 448 billion yuan at an interest rate of 1.40% on May 27, with 357 billion yuan of reverse repos maturing on the same day [1][5] - A-shares opened slightly lower but showed signs of recovery, with the Shanghai Composite Index fluctuating and turning positive [5][6] - The consumer sector, particularly food and beverage, showed initial strength, while the pharmaceutical sector rebounded [6][12] Group 2: Pharmaceutical Sector - The pharmaceutical and biotechnology sector experienced a partial rebound, with notable stocks such as Longshen Rongfa hitting the daily limit, and Sanofi Guojian rising over 10% [12][13] - Hong Kong pharmaceutical stocks also saw gains, with notable increases in companies like CSPC Pharmaceutical and China Biologic Products [8][14] Group 3: Nuclear Power Sector - The nuclear power sector continued its recent strong performance, with stocks like Shangwei Co. and Rongfa Nuclear Power achieving multiple consecutive gains [9][11] - Recent reports indicate a positive outlook for the controllable nuclear fusion industry, driven by favorable policies and increased financing [11] Group 4: Food and Beverage Sector - The food and beverage sector saw a surge, with stocks like Kuaijishan and Junyao Health achieving significant gains [15][16] - Kuaijishan's market capitalization surpassed that of Guyue Longshan, establishing it as a leading player in the yellow wine industry [15] Group 5: Cultivated Diamond Sector - The cultivated diamond sector experienced a sharp rise, with stocks like Huanghe Xuanfeng and Huifeng Diamond hitting the daily limit [17][18] - Huanghe Xuanfeng announced a partnership to establish a joint venture focused on advanced semiconductor materials, which is expected to enhance the development of high-performance thermal materials [19]

Group 1: Investor Relations Activities - The company participated in the "2025 Investor Online Reception Day" organized by the Henan Securities Regulatory Bureau and other associations on May 22, 2025 [3] - The event was held on the investor relations interactive platform [3] - Attendees included the company's board secretary and securities representative [3] Group 2: Industry Position and Innovation - The company aims to maintain its leading position through continuous technological innovation and product upgrades [5] - Future plans include benchmarking against top-tier companies and enhancing external collaborations [5] - R&D investment accounted for 10.06% of revenue in 2024, focusing on CVD diamond semiconductor applications and nano-level powder technology [7] Group 3: Core Competitiveness - The company's core competitiveness lies in ongoing technical research, product innovation, and refined management to enhance product quality and brand image [6] - The sales revenue of diamond micro-powder and diamond crushing materials decreased by 51.80% and 76.02% respectively, while other business revenues increased by 10.39% due to expanded sales efforts [7] Group 4: Market Expansion Strategies - The company primarily focuses on the domestic market, with a relatively small overseas market share [8] - In 2024, the sales team actively participated in domestic and international exhibitions to enhance brand visibility [9] Group 5: Financial Performance and Shareholder Relations - In 2024, the company reported a significant decline in performance, impacting shareholder returns [10] - The company plans to balance shareholder interests with business development through dividends and other actions [10] Group 6: Cost Reduction and Efficiency Improvement - Specific measures taken in 2024 included optimizing production processes and reducing unnecessary expenditures [10] - The company aims to enhance operational efficiency and manage costs effectively in the future [10]

Market Overview - The Shanghai Composite Index closed at 3380.45 points, above the five-day moving average, with a gain of 0.38% [1] - The total trading volume of A-shares reached 752.206 billion yuan [1] Stocks Performance - A total of 730 A-shares have surpassed the five-day moving average today [1] - Notable stocks with significant deviation rates include: - Fulejia (Code: 301371) with a deviation rate of 8.24% and a daily increase of 12.17% [1] - Huahai Pharmaceutical (Code: 600521) with a deviation rate of 7.56% and a daily increase of 10.00% [1] - Aofei Entertainment (Code: 002292) with a deviation rate of 7.46% and a daily increase of 10.02% [1] Deviation Rate Rankings - The top stocks with the highest deviation rates from the five-day moving average include: - Fulejia: Latest price 36.05 yuan, five-day moving average 33.31 yuan [1] - Huahai Pharmaceutical: Latest price 15.62 yuan, five-day moving average 14.52 yuan [1] - Aofei Entertainment: Latest price 9.77 yuan, five-day moving average 9.09 yuan [1] - Other notable stocks with high daily turnover rates include: - Huifeng Diamond (Code: 839725) with a daily increase of 9.56% and a turnover rate of 14.77% [1] - Beiningmei (Code: 002570) with a daily increase of 10.07% and a turnover rate of 22.33% [1]

Group 1: Financial Performance - The company's operating revenue and net profit declined due to a sluggish domestic and international economic environment, along with fluctuations in upstream and downstream industries, leading to decreased product sales and price volatility [5] - In 2024, the sales revenue from cultivated diamonds was 3.9293 million yuan, with increased market competition and significant price fluctuations [9] Group 2: Business Composition - The company primarily engages in the research, production, and sales of synthetic diamond single crystal micro-powder and CVD diamond materials, with diamond micro-powder and crushed materials accounting for approximately 90% of its revenue, while other products contribute about 10% [6] Group 3: Strategic Investments - The investment in the subsidiary, Xuanfeng New Materials, aims to extend the industrial chain and promote upstream and downstream collaboration, as the subsidiary's products require the company's diamond micro-powder [7] Group 4: Future Plans - For 2025, the company plans to focus on diamond micro-powder as its main business, control costs, expand the market, innovate processes, and explore new applications for functional diamond products in sectors like semiconductors and optics [8]

证券代码：839725 证券简称：惠丰钻石 公告编号：2025-036 惠丰钻石股份有限公司 2024 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 三、 参加人员 公司董事长、总经理：王来福先生； 公司财务总监：李秀英女士； 公司董事会秘书：万磊先生； 中国银河证券股份有限公司保荐代表人：李雪斌先生。 四、 投资者参加方式 本次说明会采用网络方式召开。 为充分尊重投资者、提升交流的针对性，现就公司本次业绩说明会提前向投 资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2025 年 5 月 13 日（星期二）15:00 前登录上证路演中心网站首页，点击"提问预征集"栏目 （https://roadshow.cnstock.com/wtzj/839725），或扫描下方二维码，进入问 题征集专题页面。公司将在业绩说明会上，对投资者普遍关注的问题进行回答。 欢迎广大投资者积极参与。 惠丰钻石股份有限公司（以下简称"公司"）已于 2025 年 4 月 ...

中国银河证券股份有限公司 关于惠丰钻石股份有限公司 使用闲置募集资金暂时补充流动资金的核查意见 中国银河证券股份有限公司（以下简称"保荐机构"）作为惠丰钻石股份有 限公司（以下简称"惠丰钻石"或"公司"）向不特定合格投资者公开发行并在 北交所上市的保荐机构，根据《证券发行上市保荐业务管理办法》《北京证券交 易所股票上市规则》等相关法律、法规和规范性文件的规定，对惠丰钻石使用闲 置募集资金暂时补充流动资金事项进行核查，具体核查情况如下： 一、募集资金基本概况 惠丰钻石于 2022 年 6 月 16 日收到中国证券监督管理委员会下发的《关于同 意柘城惠丰钻石科技股份有限公司向不特定合格投资者公开发行股票注册的批 复》（证监许可[2022]1243 号），同意公司向不特定合格投资者公开发行股票的 注册申请。公司本次发行价格为 28.18 元/股，发行股数为 1,265.00 万股（超额配 售选择权行使后），募集资金总额为人民币 35,647.70 万元，扣除相关发行费用 后，实际募集资金净额为人民币 32,903.27 万元。截至 2022 年 8 月 17 日，上述 募集资金已到账，并由天职国际会计师事务所（特殊 ...